Easterly Investment Partners’s Athira Pharma ATHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-33,500
| Closed | -$9.54K | – | 191 |
|
|
2025
Q1 | $9.54K | Hold |
33,500
| – | – | ﹤0.01% | 185 |
|
|
2024
Q4 | $19.7K | Hold |
33,500
| – | – | ﹤0.01% | 196 |
|
|
2024
Q3 | $14.9K | Hold |
33,500
| – | – | ﹤0.01% | 201 |
|
|
2024
Q2 | $88.8K | Hold |
33,500
| – | – | 0.01% | 195 |
|
|
2024
Q1 | $91.8K | Sell |
33,500
-1
| -0% | -$3 | 0.01% | 202 |
|
|
2023
Q4 | $81.4K | Hold |
33,501
| – | – | 0.01% | 187 |
|
|
2023
Q3 | $67.7K | Hold |
33,501
| – | – | 0.01% | 180 |
|
|
2023
Q2 | $98.8K | Hold |
33,501
| – | – | 0.01% | 188 |
|
|
2023
Q1 | $83.8K | Hold |
33,501
| – | – | 0.01% | 183 |
|
|
2022
Q4 | $106K | Buy |
33,501
+1
| +0% | +$3 | 0.01% | 181 |
|
|
2022
Q3 | $99K | Hold |
33,500
| – | – | 0.01% | 180 |
|
|
2022
Q2 | $102K | Hold |
33,500
| – | – | 0.01% | 181 |
|
|
2022
Q1 | $452K | Buy |
33,500
+6,000
| +22% | +$81K | 0.03% | 167 |
|
|
2021
Q4 | $358K | Buy |
+27,500
| New | +$358K | 0.03% | 175 |
|